Sort
78,016 grants matching “breast cancer”
Chemical, structural and molecular rules for fully antagonizing the estrogen receptor
$542,640Kendall W Nettles · Scripps Florida · R01 · FY2019 · CA
Reducing disparities in colorectal cancer screening in Vietnamese Americans
$542,634Bang H Nguyen · Cancer Prevention Instit Of California · R01 · FY2011 · CA
COHORT MANAGEMENT
$542,610Patricia L Blount · Fred Hutchinson Cancer Research Center · P01 · FY2015 · CA
Biomarkers of Molecular Age to Predict the Toxicity of Cancer Chemotherapy
$542,587Hyman B Muss · Univ Of North Carolina Chapel Hill · R01 · FY2017 · CA
High-Resolution Whole-Breast MRI at 3.0T
$542,524Brian Andrew Hargreaves · Stanford University · R01 · FY2010 · EB
Environment and Cancer Epidemiology
$542,488Alexandra White · National Institute Of Environmental Health Sciences · ZIA · FY2019 · ES
Patient-Clinician Information Exchange: Determinants and Effects on Health Behavi
$542,486Robert C. Hornik · University Of Pennsylvania · P20 · FY2011 · CA
DEVELOPMENTAL FUNDS (Core 002)
$542,437Nancy E Davidson · University Of Pittsburgh At Pittsburgh · P30 · FY2015 · CA
Using Physiological Age to Predict Chemotherapy Toxicity
$542,387Jeanne Mandelblatt · Georgetown University · R01 · FY2011 · CA
The role of the mTOR signaling pathway in ER-positive breast cancer
$542,286Marina K Holz · Yeshiva University · R15 · FY2013 · CA
Clinical, Basic, Translational and Kinetic Studies of Drug Action and Resistance
$542,286Antonio Fojo · Division Of Clinical Sciences - Nci · ZIA · FY2014 · CA
Cancer Center Support Grant
$542,255Alan Ashworth · University Of California, San Francisco · P30 · FY2015 · CA
Antigen-Presenting Cell Control of CD8+ T Cell Exhaustion in Cancer
$542,252Ming Li · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA
Antigen-Presenting Cell Control of CD8+ T Cell Exhaustion in Cancer
$542,252Ming Li · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA
Determining the Fate of Transmembrane Proteins
$542,239Allan M Weissman · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Impact of chromosomal instability on sensitivity to microtubule-targeting drugs in breast cancer
$542,209Beth A Weaver · University Of Wisconsin-Madison · R01 · FY2020 · CA
Discovery and validation of early molecular breast cancer risk markers in benign breast disease
$542,205Christopher B Umbricht · Johns Hopkins University · R01 · FY2019 · CA
Immune Enhancement and Therapy of Cancer
$542,182University Of California San Francisco · U01 · FY2004 · CA
Modeling response to MAPK Inhibitors
$542,126Wolfgang Michael Korn · Oregon Health & Science University · U54 · FY2012 · CA
Multiparameter single-cell genomics platform for personalized treatment of cancer
$542,097Eric Brouzes · State University New York Stony Brook · R01 · FY2017 · CA
Shutter-Speed Model DCE-MRI for Assessment of Response to Cancer Therapy
$542,095Wei Huang · Oregon Health & Science University · U01 · FY2013 · CA
AILENCING CHEMOKINE SIGNALING IN TUMOR-CONDITIONED MYELOID CELLS FOR THE TREATMENT OF BREAST CANCER
$542,067University Of Miami · · FY2013 · Department of Defense
Targeting FTO to treat acute myeloid leukemia
$542,055Jianjun Chen · Beckman Research Institute/City Of Hope · R01 · FY2024 · CA
Promoting Cancer Prevention/Control with Message Framing
$542,052Peter Salovey · Yale University · R01 · FY2010 · CA
Quantitative PET Imaging of Hepatocellular Carcinoma (HCC)
$542,018Henry Charles Manning · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA